ZAI LAB LTD-ADR (ZLAB)
US98887Q1040 - ADR
ZAI LAB LTD-ADR
NASDAQ:ZLAB (5/16/2024, 7:27:27 PM)
After market: 19.93 0 (0%)19.93
-0.92 (-4.41%)
Company Profile
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-09-28. The firm is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The firm has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.
Company Info
ZAI LAB LTD-ADR
4560 Jinke Road, Bldg. 1, 4/F, Pudong
Shanghai SHANGHAI 201210
CEO: Samantha (Ying) Du
Employees: 1194
Website: https://www.zailaboratory.com/
ZLAB News
14 hours ago - Zai Lab LimitedZai Lab Announces Participation in May and June Investor Conferences
3 days ago - Zai Lab LimitedZai Lab Announces Acceptance of Supplemental Biologics License Application with Priority Review for Efgartigimod Alfa Injection (Subcutaneous Injection) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
4 days ago - Zai Lab LimitedZai Lab Announces Approval of AUGTYRO™ (repotrectinib) for Patients with ROS1-positive NSCLC by China’s NMPA
7 days ago - FinancialNewsMediaFight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:ZLAB),(NASDAQ:NTBL),(NASDAQ:CRDF),(NYSE:JNJ) EQNX::TICKER_END
7 days ago - FN Media GroupFight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036/PRNewswire/ -- The incidence of pancreatic cancer is increasing globally, which is driving the growth of the market. As of 2023, the American Cancer Society...
7 days ago - ChartmillGapping stocks in Thursday's sessionThe market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
ZLAB Twits
Here you can normally see the latest stock twits on ZLAB, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
